Fluorescence in situ hybridization (FISH) probes have become a cornerstone of cytogenetic analysis in hematological malignancies. These targeted probes allow for the detection of specific chromosomal abnormalities associated with various leukemias and myelodysplastic syndromes (MDS). This white paper will explore the importance of FISH probes for Chronic Lymphocytic Leukemia (CLL) and Myelodysplastic Syndromes (MDS)The post FISH and Cytogenetic Analysis: Probing for CLL and MDS appeared first on Biocare Medical.
Biocare is a California-based medical device company that manufactures and supplies primary antibodies and automated IHC medical equipment for the healthcare industry.